Hims & Hers shares have dropped, prompting questions about whether the decline presents a buying opportunity or a warning sign for investors. The company recently reported earnings, snapping a losing streak in some areas, and has also made moves to expand its offerings, including a deal with Novo Nordisk and the acquisition of Eucalyptus. Despite the recent selloff, some on Wall Street see significant potential upside for the stock.